Biophytis S.A.
(NASDAQ:BPTS)
$0.70
0.04 (6.54%)
Open: 12:11 PM
BPTS Stock Price Graph
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- YTD
- All
BPTS Stock Price Today
Biophytis S.A. (BPTS) stock declined over -0.01% intraday to trade at $0.6999 a share on NASDAQ. The stock opened with a gain of 5.71% at $0.74 and touched an intraday high of $0.80, falling -0.01% against the last close of $0.70. The Biophytis S.A. in stock market went to a low of $0.65 during the session.
BPTS Stock Snapshot
$0.70
Prev. Close
6.81 Million
Market Cap
$0.65
Day Low
$0.74
Open
N/A
Number of Shares
$0.80
Day High
N/A
P/E ratio
-8.10
EPS (TTM)
0.01
Cash Flow per Share
N/A
Free Float in %
-0.01
Book Value
8089.00
Volume
BPTS Stock Price History Chart
| Date | Open | High | Low | Close | Volume |
|---|
Contact Details
Company Information
EmployeesN/A
Beta1.04
Sales or RevenueN/A
5Y Sales Change0.00%
Fiscal Year EndsDec. 2022
SectorHealthcare
IndustryBiotechnology
About Company
Biophytis S.A., a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases. Its therapeutics focuses on targeting and activating key biological resilience pathways that could protect against and counteract the effects of the multiple biological and environmental stresses that lead to age-related diseases. The company's lead drug candidate is Sarconeos (BIO101), an orally administered small molecule in development for the treatment of neuromuscular diseases, including sarcopenia and Duchenne muscular dystrophy (DMD), as well as in Phase 2/3 clinical study for the treatment of severe respiratory failure in patients suffering from COVID-19. It also develops Macuneos (BIO201), an orally administered small molecule for the treatment of retinal diseases, including dry age-related macular degeneration (AMD) and Stargardt disease. Biophytis SA has a collaboration agreement with AFM-Telethon for the development of its Sarconeos (BIO101) for the treatment of DMD. The company was incorporated in 2006 and is headquartered in Paris, France.
Peers
Frequently Asked Questions
What is the current Biophytis S.A. (BPTS) stock price?
Biophytis S.A. (NASDAQ: BPTS) stock price is $0.70 in the last trading session. During the trading session, BPTS stock reached the peak price of $0.80 while $0.65 was the lowest point it dropped to. The percentage change in BPTS stock occurred in the recent session was -0.01% while the dollar amount for the price change in BPTS stock was $-0.00.
BPTS's industry and sector of operation?
The NASDAQ listed BPTS is part of Biotechnology industry that operates in the broader Healthcare sector. Biophytis S. A.
Who are the executives of BPTS?
Mr. Stanislas Veillet Ph.D.
Chairman & Chief Executive Officer
Mr. Waly Dioh
Chief Operating Officer
Mr. Stanislas Veillet Ph.D.
Chairman & CEO
Mr. Benoit Canolle
Chief Bus. Officer
How BPTS did perform over past 52-week?
BPTS's closing price is 0.08% higher than its 52-week low of $0.6501 where as its distance from 52-week high of $9.02 is -0.78%.
How many employees does BPTS have?
Number of BPTS employees currently stands at N/A. BPTS operates from Sorbonne University, Paris, 75005, FR.
Link for BPTS official website?
Official Website of BPTS is: https://www.biophytis.com
How do I contact BPTS?
BPTS could be contacted at phone #33 1 44 27 23 00 and can also be accessed through its website. BPTS operates from Sorbonne University, Paris, 75005, FR.
How many shares of BPTS are traded daily?
BPTS stock volume for the day was 8089.00 shares. The average number of BPTS shares traded daily for last 3 months was 1.12 Million.
What is the market cap of BPTS currently?
The market value of BPTS currently stands at $6.81 Million with its latest stock price at $0.70 and N/A of its shares outstanding.